THIS MONTH’S ISSUE

Read, save, and print articles from the current issue

ARTICLES

Chronological index
2013–2018

PRODUCT GUIDES

Compare all instruments
and software systems

DEPARTMENTS

Chronological index
2013–2018

WEBINARS

Register Now and
On Demand

Home » Category

Top news

Agena expands genetic testing ISO accreditation

Aug. 22, 2016—Agena Bioscience announced the accreditation of its Assays by Agena facility in Brisbane, Australia, under ISO/IEC 17025 in …

ArcherDx NGS assays get conditional NY approval

Aug. 19, 2016—ArcherDx said that two of its FusionPlex NGS assays have received conditional approval from the New York State …

Study examines biomarkers for early breast cancers

Aug. 19, 2016—Provista Diagnostics said a study it conducted, published in PLoS One, shows that a combined assessment of multiple …

FDA clears automated IFA system

Aug. 18, 2016—Aesku Group has received 510(k) clearance from the Food and Drug Administration for its new Helios Automated IFA …

Enzo offers nanopolymer ISH, IHC reagents

Aug. 18, 2016—Enzo Life Sciences has introduced a new line of in situ hybridization and immunohistochemistry reagents and their complementary …

Helmer launches countertop refrigerator

Aug. 17, 2016—Helmer Scientific has announced the release of the new MLR102 medical-grade countertop refrigerator with AdvanceCore cooling technology. This …

Sample tracking added to WindoPath, NucleoLIS

Aug. 17, 2016—Leica Biosystems announced the integration of its Cerebro Sample Tracking System with Psyche Systems’ WindoPath and NucleoLIS products. …

Roche’s test for flu A/B and RSV waived

Aug. 16, 2016—Roche announced that the Food and Drug Administration has granted 510(k) clearance and a CLIA waiver for the …

Luminex lands EUA for molecular Zika test

Aug. 17, 2016—Luminex has received emergency use authorization from the FDA for a multiplex nucleic acid test designed to detect …

Successful Keytruda trial stopped early

Aug. 5, 2016—The KEYNOTE-024 trial investigating the use of Merck’s Keytruda (pembrolizumab) in patients with previously untreated advanced non-small cell …

X